Personal information

Ireland

Activities

Employment (1)

Dublin City University: Dublin, IE

2023-03-01 to present | Associate Professor (School of Biotechnology)
Employment
Source: Self-asserted source
Naomi Walsh

Education and qualifications (1)

University College Dublin: Dublin, Dublin, IE

2012-09-08 to 2013-07-04 | MPH
Education
Source: Self-asserted source
Naomi Walsh

Works (35)

Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma

Cancers
2024-08-17 | Journal article
Contributors: Sarah Powell; Karina Kulakova; Katie Hanratty; Rizwana Khan; Paula Casserly; John Crown; Naomi Walsh; Susan Kennedy
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostic Value of BAP1 Protein Expression in Uveal Melanoma

American Journal of Surgical Pathology
2024-03 | Journal article
Part of ISSN: 0147-5185
Contributors: Susan Kennedy; Sally Owens; Laura Ivers; Ciara Hegarty; Valerie O’Neill; Jose J. Berenguer-Pina; Noel Horgan; John Crown; Naomi Walsh
Source: Self-asserted source
Naomi Walsh

An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer

European Journal of Medicinal Chemistry
2024-02 | Journal article
Part of ISSN: 0223-5234
Contributors: Samuel H. Myers; Laura Poppi; Francesco Rinaldi; MARINA VERONESI; Andrea Ciamarone; Viola Previtali; Greta Bagnolini; Fabrizio Schipani; Jose Antonio Ortega Martínez; Stefania Girotto et al.
Source: Self-asserted source
Naomi Walsh

Phototoxicity of Tridentate Ru(II) Polypyridyl Complex with Expanded Bite Angles toward Mammalian Cells and Multicellular Tumor Spheroids

Inorganic Chemistry
2023-08-14 | Journal article
Part of ISSN: 0020-1669
Part of ISSN: 1520-510X
Contributors: Rhianne C. Curley; Christopher S. Burke; Karmel S. Gkika; Sara Noorani; Naomi Walsh; Tia Keyes
Source: Self-asserted source
Naomi Walsh

Data from Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk

2023-03-31 | Preprint
Contributors: Fangcheng Yuan; Rayjean J. Hung; Naomi Walsh; Han Zhang; Elizabeth A. Platz; William Wheeler; Lei Song; Alan A. Arslan; Laura E. Beane Freeman; Paige Bracci et al.
Source: check_circle
Crossref

Data from Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk

2023-03-31 | Preprint
Contributors: Fangcheng Yuan; Rayjean J. Hung; Naomi Walsh; Han Zhang; Elizabeth A. Platz; William Wheeler; Lei Song; Alan A. Arslan; Laura E. Beane Freeman; Paige Bracci et al.
Source: check_circle
Crossref

Supplementary Tables from Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk

2023-03-31 | Preprint
Contributors: Fangcheng Yuan; Rayjean J. Hung; Naomi Walsh; Han Zhang; Elizabeth A. Platz; William Wheeler; Lei Song; Alan A. Arslan; Laura E. Beane Freeman; Paige Bracci et al.
Source: check_circle
Crossref

Supplementary Tables from Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk

2023-03-31 | Preprint
Contributors: Fangcheng Yuan; Rayjean J. Hung; Naomi Walsh; Han Zhang; Elizabeth A. Platz; William Wheeler; Lei Song; Alan A. Arslan; Laura E. Beane Freeman; Paige Bracci et al.
Source: check_circle
Crossref

Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo

Organoids
2022-12 | Journal article | Author
Contributors: Sara Noorani; Shannon Nelson; Neil Conlon; Justine Meiller; Ekaterina Shcheglova; Alice Usai; Jojanneke Stoof; Letizia Palanga; Fiona O’Neill; Sandra Roche et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes

Medical Sciences
2022-05 | Journal article | Author
Contributors: Charlotte Andrieu; Niamh McNamee; Anne-Marie Larkin; Alanna Maguire; Roopika Menon; Judith Mueller-Eisert; Noel Horgan; Susan Kennedy; Giuseppe Gullo; John Crown et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives.

Frontiers in cell and developmental biology
2021-10-12 | Journal article
Source: Self-asserted source
Naomi Walsh

Hindsight: Review of Preclinical Disease Models for the Development of New Treatments for Uveal Melanoma.

Journal of Cancer
2021-06-04 | Journal article
Source: Self-asserted source
Naomi Walsh

Os(II)-Bridged Polyarginine Conjugates: The Additive Effects of Peptides in Promoting or Preventing Permeation in Cells and Multicellular Tumor Spheroids.

Inorganic chemistry
2021-05-12 | Journal article
Source: Self-asserted source
Naomi Walsh

Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify <i>SOX13</i> to Be Involved in Invasion and Progression of Pancreatic Cancer.

Journal of oncology
2020-12-24 | Journal article
Source: Self-asserted source
Naomi Walsh

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer

British Journal of Cancer
2020-10-13 | Journal article
Contributors: Naomi Walsh; Charlotte Andrieu; Peter O’Donovan; Cecily Quinn; Alanna Maguire; Simon J. Furney; Giuseppe Gullo; John Crown
Source: check_circle
Crossref

Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk.

Cancer research
2020-07-08 | Journal article
Source: Self-asserted source
Naomi Walsh
grade
Preferred source (of 2)‎

Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients.

Cancers
2020-05-14 | Journal article
Source: Self-asserted source
Naomi Walsh

Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.

Investigational new drugs
2020-04-22 | Journal article
Source: Self-asserted source
Naomi Walsh

Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.

Scientific reports
2020-02-17 | Journal article
Source: Self-asserted source
Naomi Walsh

Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.

Journal of the National Cancer Institute
2019-06-01 | Journal article
Source: Self-asserted source
Naomi Walsh

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.

Cancers
2019-04-17 | Journal article
Source: Self-asserted source
Naomi Walsh

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.

BMC cancer
2018-10-11 | Journal article
Source: Self-asserted source
Naomi Walsh

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the "one thousand HER2 patients" project.

British journal of cancer
2018-05-18 | Journal article
Source: Self-asserted source
Naomi Walsh

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.

Investigational new drugs
2018-02-02 | Journal article
Source: Self-asserted source
Naomi Walsh

A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2016-09-06 | Journal article
Source: Self-asserted source
Naomi Walsh

7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2014-04-18 | Journal article
Source: Self-asserted source
Naomi Walsh

EGFR and HER2 inhibition in pancreatic cancer.

Investigational new drugs
2012-10-18 | Journal article
Source: Self-asserted source
Naomi Walsh

RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.

Cancer letters
2011-04-05 | Journal article
Source: Self-asserted source
Naomi Walsh

Challenges of drug resistance in the management of pancreatic cancer.

Expert review of anticancer therapy
2010-10-01 | Journal article
Source: Self-asserted source
Naomi Walsh

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis.

British journal of cancer
2010-03-16 | Journal article
Source: Self-asserted source
Naomi Walsh

Alterations in integrin expression modulates invasion of pancreatic cancer cells.

Journal of experimental & clinical cancer research : CR
2009-10-13 | Journal article
Source: Self-asserted source
Naomi Walsh

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma.

BMC urology
2009-06-24 | Journal article
Source: Self-asserted source
Naomi Walsh

Identification of pancreatic cancer invasion-related proteins by proteomic analysis.

Proteome science
2009-02-14 | Journal article
Source: Self-asserted source
Naomi Walsh

Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells.

Proteomics
2008-10-01 | Journal article
Source: Self-asserted source
Naomi Walsh

Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells.

Journal of proteomics
2008-09-25 | Journal article
Source: Self-asserted source
Naomi Walsh

Peer review (2 reviews for 2 publications/grants)

Review activity for Eye and vision. (1)
Review activity for Nature communications (1)